Document is current
Any future updates will be listed below
-
Authors
Zhanfang, Xie https://orcid.org/0000-0003-0606-2184
Yan, Hu https://orcid.org/0000-0003-0788-8308
Yanhong, Wang
Liujin, Luo
Ganggang, Li https://orcid.org/0000-0002-2357-9866
Jing, Zhou https://orcid.org/0000-0002-0971-1867
-
Funding
Funding for this research was provided by:
Youth Cultivation Plan Project of the Fifth Affiliated Hospital of Zhengzhou University in 2025 (NO.YQ2024016)
Jointly Co-built Project of the 2025 Henan Provincial Medical Science and Technology Research Program (LHGJ20250406)
Key Research and Development and Promotion Special Projects of Henan Province (No.242102311279)
Special Project for Traditional Chinese Medicine Research of Henan Province (NO.2025ZY3149)
- License Information
-
More Information
Article History
Received: 30 August 2025
Accepted: 26 March 2026
First Online: 27 April 2026
Declarations
:
: Not applicable. The FDA Adverse Event Reporting System is a voluntary reporting system wherein publicly available data are anonymized. Consequently, it does not necessitate obtaining informed consent for participation.
: The authors declare no competing interests.
